Neil Shen
沈南鹏
Neil Shen is the founding and managing partner of Sequoia China (now HSG), the firm behind some of China's most lucrative venture bets — among investors active in the primary market, he ranked 148th on a 2024 rich list, ahead of Hillhouse's Zhang Lei at 179th . The Pinduoduo deal captures his style: Sequoia passed on the company early in 2015, then "came back with a vengeance" at the C round in late 2016 after Alex Fang re-pitched it to Shen — as 暗涌Waves put it, "correcting course promptly and decisively, then piling in, is exactly why Neil Shen is Neil Shen" . He's also been one of the earliest movers on AI: after meeting with OpenAI he was reportedly "deeply shaken" and told his team to "get moving," personally meeting figures like Harry Shum, Yang Zhilin, and Alibaba CTO Zhou Jingren . He has framed Sequoia's seed fund as a "semi-philanthropic" bet on cultivating founders, balancing public good with commercial returns .
AI-generated — may contain errors, please verify.
Coverage
SHEIN's Fundraising History
Tales from China's Investment Past: ______.
The Unforgettable Series C Funding of Moonshot AI
A stroke of genius.
Sequoia Capital China: And I Choose to Start a New Table
Sequoia Capital China's culture is about winning and conviction.
Sp.02 | A Conversation with Master Dong: The Untold Stories Behind 20 Years of Chinese Venture Capital
A Sidebar Conversation with Master Dong on 20 Years of Chinese Venture Capital
Happy New Year!
A Conversation with Sam Guo: Staying Out of the Fray, but Keeping on Winning
Truck drivers, sour kiwis, counterfeit cigarettes and booze — and the legends of investing.
Exclusive | Airwallex Raises Another $330 Million, Hits $8 Billion Valuation Today
The Saved and the Saved.
Pony.ai's Funding Story: Daydreams in a Winter Storm
The final exam is approaching.
10 Facts About 1,000 Chinese Billionaires
The currents of the era, all contained within the sequence.
Who Is Horizon Robotics' Most Important Investor?
Got it?
The VC 2.0 generation celebrated its tenth birthday in early autumn.
What about the next decade?
Who's Standing on the Founders' Side in the Buyback Wave?
Those without ideals feel no sorrow.
When I Was One Step Away from the Founder | Z Talk
Ostrich Club Members' Entrepreneurial Stories, Revealed for the First Time Ever.
A New Decade for Venture Capital: Hongshan's First Answer
What's the solution for early-stage investing?
Goodbye to a Decade of Venture Capital | Waves' Second Anniversary
Keep moving forward. Don't look back.
Who's Who in Shenzhen Capital Group's New Leadership Team
To study an organization, start with the people.
Two Masterstrokes in NIO's Fundraising History
There is no successful fundraising, only fundraising of the times.
The Investor Who Made the Most Money Off Pinduoduo
"Though millions may oppose me, I will go."
Trekking to Riyadh
Opportunity, wealth, and a surging tide of people.
200 Days of Frenzy: China's LLM Wars Stuck in a Stalemate
Consensus can form quickly — and dissolve just as fast.
Two Decades of RMB Funds: Between Life and Death
Are USD Funds in Trouble? Is It the RMB Funds' Turn to Make a Move?
Synthetic biology company Bota Bio (Enhe Biotechnology) announced the completion of a Series B funding round exceeding $100 million, with existing shareholder Source Code Capital continuing to increase its stake.
Accelerating the design and production of high-performance, sustainable products through synthetic biology.
The Gaorong Ventures Way: Know What to Do, Know What Not to Do
A matter of resolve.
The "Oscars of Global Investing" Unveiled: Source Code Capital's Yi Cao Makes Forbes' 2018 Midas List
Yi Cao of Source Code Capital made the *Forbes* 2018 Midas List, recognized as the youngest best investor globally.
Yi Cao Named to 2017 China Top Venture Capitalists TOP50
Jiemian and Toutiao jointly released the "Top Venture Capitalists in China" list for the first time.
Yi Cao: Source Code Capital's "Three Horizontals, Nine Verticals" Investment Map
Where, when, and by whom will the next major innovation opportunity emerge?
